Kantoff Philip W.
Reporting Owner SEC Filing List

CIK: 0001866025
FormFilerSubject CompanyFiling AgentDateActions
4Statement of changes in beneficial owner...Context Therapeutics Inc.Context Therapeutics Inc. /fa06/12/2025
4Statement of changes in beneficial owner...Kantoff Philip W.Context Therapeutics Inc. /fa06/12/2025
4Statement of changes in beneficial owner...Context Therapeutics Inc.06/14/2024
4Statement of changes in beneficial owner...Kantoff Philip W.Context Therapeutics Inc. /fa06/14/2024
4Statement of changes in beneficial owner...Essa Pharma Inc.Skadden Arps Slate Meagher & Flom Llp /fa /fa03/28/2024
4Statement of changes in beneficial owner...Kantoff Philip W.Skadden Arps Slate Meagher & Flom Llp /fa /fa03/28/2024
4Statement of changes in beneficial owner...Kantoff Philip W.Context Therapeutics Inc. /fa05/31/2023
4Statement of changes in beneficial owner...Context Therapeutics Inc.05/31/2023
4Statement of changes in beneficial owner...Kantoff Philip W.Context Therapeutics Inc. /fa05/31/2023
3Initial statement of beneficial ownershi...Essa Pharma Inc.Donnelley Financial Solutions File16 /fa09/21/2022
Load More

Kantoff Philip W. 's Ownership Transactions

IssuerFiling
Date
Transaction
Date
Transaction
Type
SharesPriceTotal AmtShares Owned